NASDAQ · BLLNHealthcareMedical Labs

BillionToOne financials

$118.18−2.91%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

QuarterQ2 '26
Jun 30
Q1 '26
Mar 31
Q4 '25
Dec 31
Revenue$109.4M$108.4M$96.1M
Gross profit$77.1M$79.1M$68.6M
Gross margin70.5%73.0%71.4%
Operating income$5.5M$17.8M$10.3M
Net income$8.1M$18.0M$2.5M
Net margin7.4%16.6%2.6%
Diluted EPS$0.15$0.34$0.05
EBITDA$7.3M$19.6M$12.0M
Operating cash flow$9.1M$15.4M$10.8M
Free cash flow$5.1M$11.0M$9.3M
Diluted shares54.5M53.0M48.7M

Balance sheet

Period endJun 30Mar 31Dec 31
Cash & equivalents$548.6M$537.5M$496.0M
Short-term investments$0.00$0.00$0.00
Total debt$91.6M$90.7M$58.1M
Total assets$729.7M$700.7M$632.7M
Total liabilities$192.9M$195.1M$152.5M
Shareholders' equity$536.8M$505.6M$480.1M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology